The constitutive NF-κB DNA-binding activity associated with the increased expression of RelA was first demonstrated in PTC- and ATC-derived cell lines [15], followed by the nuclear localization of RelA in PTC, FTC and ATC tumor tissues [16–18]. The gene discussed is RELA; the disease is thyroid cancer, nonmedullary, 2.